REVIEW  EVOLVING TECHNOLOGIES FOR INFRA-INGUINAL ARTERIAL DISEASE 

The Journal of Cardiovascular Surgery 2018 August;59(4):512-25

DOI: 10.23736/S0021-9509.18.10599-4

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

The use of drug-coated balloons in the treatment of femoropopliteal and infrapopliteal disease

Jun LI ^{1, 2}, Adham KARIM ¹, Mehdi H. SHISHEHBOR ^{1, 2} ✉

¹ Division of Cardiovascular Medicine, Department of Interventional Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; ² Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA

While the field of endovascular interventions has evolved in the last decade, technological advancements have rendered drug-coated balloons (DCBs) to be the first line therapy for femoropopliteal artery disease. As the knowledge continues to advance, the application of DCB to the infrapopliteal segments as well as its role in in conjunction with plaque modification to minimize stent utilization, will be further elucidated.

KEY WORDS: Balloon angioplasty - Femoral artery - Popliteal artery - Peripheral arterial disease